# LLM call: summary

- Turn: 3
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 736
- Completion tokens: 543
- Total tokens: 1392
- Cost (USD): 0.000183

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1446: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn intrusions mapped power, ports and water systems in EU and beyond using openly released AI tooling, detected accidentally. Brussels agreed a hardening pact — joint ENISA detection, exercised plans, mandatory reporting, funded by repurposed funds and EIB loans — but rollout was uneven, reporting stayed voluntary, and US support stalled.

In H1 2027 two shocks hit: an automated AI-assisted ransomware sweep crippled municipal services and a hospital network across member states with no attribution, and a genome model demonstrated viable human-infective pathogen design shortly before a near-frontier open-weight release was downloaded hundreds of thousands of times and became irrecoverable.

Brussels pushed the pact into crisis operation: mandatory reporting passed, loans front-loaded for operators sharing live telemetry, mutual-aid teams deployed, though compliance remained partial and defenders lagged. On biology it launched a Shield via health emergency and disease-control agencies — port/hospital sequencing, joint countermeasure procurement, and a deal with the publisher-university moratorium group to divert risky preprints to secure review, which split researchers. Compute permitting stalled as grid capacity was diverted to hospitals and water; Washington stayed distant. By June detection improved but stayed patchy, trust in digital services fell sharply, support for protection held by necessity.

CURRENT NARRATIVE:
### Loose weights, tight vise
Autumn brings the release everyone feared. A new open-weight system lands only months behind the closed frontier and spreads to hundreds of thousands of machines in days. University labs test it; so do ransomware crews and bio hobbyist forums. What it can do cannot be taken back. At the same time, method papers for AI-assisted pathogen design keep circulating despite the moratorium, with copies appearing on mirror sites abroad within hours of refusal at home.

Brussels gets its hardening pact over the line. Reporting becomes mandatory, grid operators share live telemetry for front-loaded loans, and mutual-aid teams stay in the field. Hospitals restore appointment systems, though several cities remain on paper backups for weeks. Detection improves enough that ministers claim a win — privately, responders say they are still reading yesterday's logs.

### The chokepoint spent by someone else
Washington then forces The Hague to widen the cutoff on lithography servicing and spares, reaching back to older machines and other customers. The decision is presented as national security; in Eindhoven and Brussels it reads as the Union's single piece of leverage being spent without the Union.

The Commission answers with a bargaining bloc: an examination of extraterritorial bans, a reciprocal EU licence requirement, and outreach to Tokyo and Seoul for a common front, with quiet promises to cover the company's legal exposure if it slows compliance. Paris applauds, The Hague hesitates, and Tokyo stalls for time. No joint cutoff is wielded yet.

On biology, sequencing nodes go live in Rotterdam, Antwerp, Hamburg and three hospitals, and joint tenders for antivirals advance. Computing-site permits stay frozen as grid priority stays with hospitals and water, save for one ring-fenced factory site meant to show the build is alive. By December, protection feels more real, dependence feels more humiliating, and the public mood sours further.
```

## Raw response

```
Autumn intrusions mapped EU power, ports and water via open AI tools. Brussels built a hardening pact — ENISA detection, exercises, reporting, EIB loans — but rollout was uneven and US support stalled.

In H1 2027 an AI-assisted ransomware sweep hit municipalities and hospitals without attribution, while a genome model showed viable pathogen design just before a near-frontier open-weight release spread irrecoverably. Brussels moved to crisis operation: mandatory reporting, front-loaded loans for live telemetry, mutual-aid teams; and a bio Shield via health agencies — sequencing, countermeasure procurement, diverting risky preprints to secure review, splitting researchers. Compute permitting froze as grid went to hospitals/water; Washington stayed distant. Detection improved but lagged; trust fell.

In H2 2027 a new open-weight system only months behind frontier spread to hundreds of thousands in days, used by labs, ransomware crews and bio hobbyists; pathogen-design methods kept leaking to foreign mirrors despite the moratorium. The hardening pact passed fully, hospitals partly restored, detection improved but responders still behind.

Washington then forced The Hague to widen lithography servicing/spares cutoffs to older machines and customers, spending what Brussels saw as the EU's sole leverage. The Commission answered with a bargaining bloc — review of extraterritorial bans, reciprocal EU licence, outreach to Tokyo and Seoul, pledges to cover legal exposure for slowed compliance; Paris backed, The Hague hesitated, Tokyo stalled, with no joint cutoff used. Bio sequencing went live in Rotterdam, Antwerp, Hamburg and hospitals, antiviral tenders advanced; compute stayed frozen save one ring-fenced factory site. By December protection felt more real, dependence more humiliating, public mood soured further.
```
